Where does Phagos's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Phagos's 1 recorded funding rounds.

Premier Alternatives

Phagos

Suresnes, France · Founded 2021 · Privately Held (backing)

Operator of a biotechnology research company intended to provide customizable drugs to replace antibiotics in animal farming. Phagos is based in Suresnes, France and was founded in 2021. It was valued at $59.9 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $31.9 million across 1 recorded round; the latest was a $1.5 million seed round in Jul 2022.

PMV mark · valuation

$59.9M

Oct 2026

Priced at

its early-stage round

Oct 2025

Total raised

$31.9M

Last round

Seed Round

Jul 2022

Cap table — not yet on record

Phagos's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Phagos with a free account

·The complete investor list: 26 names
·Watch Phagos: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Phagos

Where does Phagos's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Phagos's 1 recorded funding rounds.